Alex Fässler
Geschäftsführer bei Targimmune Therapeutics AG
Vermögen: 3 Mio $ am 31.05.2024
Aktive Positionen von Alex Fässler
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Targimmune Therapeutics AG
 Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Geschäftsführer | - | - |
Karriereverlauf von Alex Fässler
Ehemalige bekannte Positionen von Alex Fässler
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Corporate Officer/Principal | 01.01.1998 | - |
| BACHEM HOLDING AG | Geschäftsführer | 01.01.1998 | - |
Ausbildung von Alex Fässler
| Swiss Federal Institute of Technology | Doctorate Degree |
Statistik
International
| Schweiz | 5 |
Operativ
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BACHEM HOLDING AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Health Technology |
- Börse
- Insiders
- Alex Fässler
- Erfahrung